Keyphrases
Dyskinesia
100%
Cognitive Deficits
100%
Remediate
100%
Nicotine
100%
Parkinson's Disease
100%
Nicotinic Acetylcholine Receptor (nAChR)
60%
Alpha4beta2
40%
Parkinson's Disease Model
40%
Site of Action
20%
Prescription Drugs
20%
Therapeutic Effect
20%
Cognitive Function
20%
Conventional Treatment
20%
Potential Therapeutics
20%
Cognitive Symptoms
20%
Disease-associated
20%
Effective Treatment
20%
Working Memory
20%
Executive Function
20%
Dihydro-β-erythroidine
20%
Abnormal Involuntary Movements
20%
6-Hydroxydopamine-lesioned Rats
20%
Epidemiologic Studies
20%
Tobacco Use
20%
L-DOPA
20%
Positive Allosteric Modulator
20%
Motor Function
20%
Impaired Function
20%
Receptor Antagonist
20%
Levodopa-induced Dyskinesia
20%
Site-directed
20%
Methyllycaconitine
20%
Clinically Significant
20%
Nigrostriatal Damage
20%
Rodent Models
20%
Pharmacology, Toxicology and Pharmaceutical Science
Dyskinesia
100%
Cognitive Defect
100%
Parkinson's Disease
100%
Positive Allosteric Modulator
28%
Epidemiology
14%
Therapeutic Effect
14%
Receptor Antagonist
14%
Methyllycaconitine
14%
Oxidopamine
14%
Side Effect
14%
Nicotinic Receptor Alpha4beta2
14%
Levodopa-Induced Dyskinesia
14%
Dihydro Beta Erythroidine
14%
DOPA
14%